"NeuroStudies is an experienced, clinical research group dedicated to the development of safe and effective treatments to help prevent memory loss and dementia for patients around the world. With secure, modern facilities and a committed staff, we not only remain on the forefront of medical and technology advancements, but also provide our patients and study participants with the best clinical trial experience possible. Our team works around-the-clock to help ensure patients are receiving the highest standard of care, and are well-informed, comfortable and safe."

During the past decade, NeuroStudies.net, LLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 9 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NeuroStudies.net, LLC" #1 sponsor was "Biogen" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Impax Laboratories, LLC" with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NeuroStudies.net, LLC" #1 collaborator was "Alzheimer's Association" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "NeuroStudies.net, LLC" are "Alzheimer's Disease" (7 trials), "Alzheimer Disease" (5 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Cardiovascular Disease" (2 trials) and "Parkinson Disease" (2 trials). Many other conditions were trialed in "NeuroStudies.net, LLC" in a lesser frequency.

Most popular intervention types in "NeuroStudies.net, LLC" are "Drug" (23 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "AVP-786" (2 trials), "Crenezumab" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "AGB101 220 mg tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "NeuroStudies.net, LLC" are 23 trials for "All" genders.

Currently, there are NaN active trials in "NeuroStudies.net, LLC". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in NeuroStudies.net, LLC, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in NeuroStudies.net, LLC, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".